Sylvain continues his series on short selling with a discussion of long-term opportunities. He discusses the time frame involved and when to apply this strategy using a few examples.

October went worse than expected, due to a poor performance by the ORI painlands. Read on for Sylvain’s latest report on the “1 Year, 100 Tix” project!

Matthew Lewis and Sylvain Lehoux present the MTGO Market Report for this week, discussing major price trends and recommending specific cards to buy and sell.

Matthew Lewis and Sylvain Lehoux present the MTGO Market Report for this week, discussing major price trends and recommending specific cards to buy and sell.

Kelly has been buying baskets of bulk rares on MTGO. He explains how such a strategy works and why it can be especially appealing for small bankrolls.

Today Sylvain continues his treatment of short selling on MTGO, explaining more in depth the principle instrument that enables it–speculation on full sets.

Matthew Lewis and Sylvain Lehoux present the MTGO Market Report for this week, discussing major price trends and recommending specific cards to buy and sell.

Matthew Lewis and Sylvain Lehoux present the MTGO Market Report for this week, discussing major price trends and recommending specific cards to buy and sell.

Sylvain has begun to short sell on MTGO. Using the recent example of Jace, Vryn’s Prodigy, he discusses what could be a revolution in the world of MTGO finance.

Matthew Lewis and Sylvain Lehoux present the MTGO Market Report for this week, discussing major price trends and recommending specific cards to buy and sell.

This month Modern made some room for Origins in Sylvain’s “1 Year, 100 Tix” portfolio. With only three months remaining, he discusses his plan to exit ORI positions profitably.

Matthew Lewis and Sylvain Lehoux present the MTGO Market Report for this week, discussing major price trends and recommending specific cards to buy and sell.

Matthew Lewis and Sylvain Lehoux check in with the MTGO Market Report’s mock portfolio to assess its performance over the last nine months, before offering current recommendations.